A Case study- Jalaukavacharan-Leech Therapyin management of Vranagranthi (Keloid)
DOI:
https://doi.org/10.22270/ajprd.v12i2.1377Abstract
Keloid is a type of scar that results from the overgrowth of dense fibrous tissue which is usually develops after healing of a skin injury. In other words, it represents an abnormal scar formation. The tissue extends beyond the borders of the original wound and does not usually regress spontaneously. It causes cosmetic deformity, itching, pain, and stress ultimately resulting in compromised quality of life and diminished functional performance. The treatment of Keloid is often difficult because there is an associated high risk of recurrence. Vrana represents a vast part of Shalyatantra and the pathogenesis of Keloid is similar to Vrana granthi which has been explained as a growth of mass at the site of Vrana following dietetic complications or any physical irritation in a Vrana patient. Jalaukavacharana (leech therapy) is a parasurgical type of Raktamokshana and is considered as the most unique and effective method of bloodletting. Leeches are widely used in most disorders ranging from skin disease with evidence of successful results. In the present paper, an effort has been made to case of keloid that have been conducted in Ayurveda as para surgical procedure.
Downloads
References
2. Wang J. Statin-Associated Adverse Events Prediction And Drug-Drug Interactions For Cardiovascular Disease Patients From Retrospective Claims Data. 2019.
3. Thangabalan Boovizhikannan, Pavithra Nagarajan, Pavitra Palani, Rama Rajendran, Jahnavika Seemakurthi, Zeba Nayar Ahmed. Reported Estimation techniques for Quantification of Simvastin :- A Review. World J Bio Pharm Health Sci. 2022 Nov 30;12(2):079–86.
4. PubChem - Wikipedia [Internet]. [cited 2023 Jul 15]. Available from: https://en.wikipedia.org/wiki/PubChem
5. Kommanaboyina B, Rhodes CT. Trends in stability testing, with emphasis on stability during distribution and storage. Drug Development and Industrial Pharmacy. 1999 Jan;25(7):857–68.
6. Q 1 A (R2) stability testing of new drug substances and products. 2006;20.
7. Yulianita R, Sopyan I, Muchtaridi M. forced degradation study of statins: a review. Int J App Pharm. 2018 Nov 22;10(6):38.
8. Lalchandani DS, Chenkual L, Mariappayan M, Porwal PK. Significance of stressor media on the stability of statins: a critical assessment. Chemical Papers. 2022;76(10):6047–71.
9. Husain A. Forced Degradation Studies. JAPLR [Internet]. 2016 Dec 14 [cited 2023 Aug 21];3(6). Available from: https://medcraveonline.com/JAPLR/forced-degradation-studies.html
10. Tamizi E, Jouyban A. Forced degradation studies of biopharmaceuticals: Selection of stress conditions. European Journal of Pharmaceutics and Biopharmaceutics. 2016 Jan;98:26–46.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Dr. Sejal B.Padvi, Dr. Rajesh Kumar Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.